Digestive CARE Selects eClinicalWorks for Its 67 Providers across 28 Locations
Gastroenterology Network Selects the eClinicalWorks CloudBased EHR Solution eClinicalWorks a leader in healthcare IT solutions announces that
View ArticleLyfebulb Partners with UnitedHealth Group to Support PatientDriven...
NEW YORK Jan. 17 2018 GLOBE NEWSWIRE Lyfebulb a chronic diseasefocused patientempowerment platform that connects patients industry and investors to support userdriven innovation is partnering with...
View ArticleQueens Medical Associates Launches Cancer Palliative And Supportive Care Program
Leading Oncology and Hematology Practice Appoints Dr. Pavel Groysman as DirectorFRESH MEADOWS N.Y. PRWEB January 17 2018 Queens Medical Associates a preeminent cancer care facility specializing in...
View ArticleResearchers unravel key molecular mechanism of autoimmune and inflammatory...
An international team of researchers led by prof. Savvas Savvides has unraveled a crucial aspect of the molecular basis of autoimmune and inflammatory diseases such as psoriasis rheumatoid arthritis...
View ArticleTiGenix Transparency notification pursuant to Article 14 of the Law of May 2...
ÂREGULATED INFORMATIONPRESS RELEASE Transparency notification pursuant to Article 14 of the Law of May 2 2007 Leuven Belgium January 18 2018 2200h CET TiGenix NV Euronext Brussels and Nasdaq TIG;...
View ArticleFDA accepts application for new Humira biosimilar
Sandoz announced that the FDA has accepted a biologics license application for a proposed biosimilar of the antiinflammatory drug adalimumab known commercially as Humira.Adalimumab is an antiTNF...
View ArticleNew drugs for inflammatory bowel disease IBD
American Gastroenterological Association 1.6 million Americans suffer from IBD. There is no cure for these chronic lifelong conditions. While several effective treatments are available 40 to 55 percent...
View ArticleNew strategies to improve the quality of inflammatory bowel disease IBD care
American Gastroenterological Association 1.6 million Americans suffer. As with many chronic conditions IBD patients often require frequent hospital visits due to rapid changes in their illness and can...
View ArticleBeyond drugs for IBD Improving the overall health of IBD patients
American Gastroenterological Association 1.6 million Americans suffer from IBD. Identifying the best medical treatment leads to improved disease management but IBD patients also experience mental...
View ArticlePharmaPoint Crohn's Disease Global Drug Forecast and Market Analysis to 2026...
PharmaPoint Crohn's Disease Global Drug Forecast and Market Analysis to 2026SummaryCrohn's disease CD is a form of inflammatory bowel disease IBD which is comprised of two chronic autoimmune diseases...
View ArticleUstekinumab Makes Inroads in Crohn's Disease
MedPage Today Docs opt for psoriasis drug when antiTNF agents fail
View ArticleNew clinical evidence support potential for glepaglutide as a onceweekly drug...
Company announcement No. 52018 New clinical evidence support potential for glepaglutide as a onceweekly drug for short bowel syndrome SBS Zealand has completed a pharmacokinetic PK study with...
View ArticleViaDerma Inc. Announces Plan to Target Licensed Dispensaries in California...
LOS ANGELES CAMarketwired January 23 2018 ViaDerma Inc. OTC PINK VDRM a specialty pharmaceutical company devoted to bringing new products to market announced today the Company is working with a medical...
View ArticleExperts Offer Guidance on Crosssectional Enterography in Crohns Disease
New consensus guidelines aim to standardize the use of computed tomography enterography CTE and magnetic resonance enterography MRE in Crohns disease CD patients with smallbowel disease. Reuters Health...
View ArticleDeath Rate Falls with AntiTNF in Crohn's CMECE
MedPage Today Reduced mortality seen primarily in patients with comorbidities
View ArticleCelgene Reports Fourth Quarter and FullYear 2017 Operating and Financial Results
Finished 2017 with strong operating and financial momentum Celgene recently announced two strategic transactions enhancing longterm growth prospects Celgene Corporation NASDAQCELG reported operating...
View ArticleCelgene weiter auf Expansionskurs Das Geschft mit Krebsmitteln bringt dem...
Das Geschft mit Krebsmitteln bringt dem USBiotechkonzern weiter solides Wachstum. Aber der Fehlschlag bei der Entwicklung von Medikamenten gegen die Darmkrankheit Crohn's belastet die Gewinnrechn...
View ArticleToll Like Receptor 4 hToll or CD284 or TLR4 Pipeline Review H1 2018 Report...
Toll Like Receptor 4 hToll or CD284 or TLR4 Pipeline Review H1 2018SummaryToll Like Receptor 4 hToll or CD284 or TLR4 Tolllike receptor 4 is a protein encoded by the TLR4 gene. This receptor is mostly...
View ArticleuBiome the Leader in Microbial Genomics Launches SmartGut and SmartJane...
Kits can be requested online; all requests are reviewed by a licensed healthcare provider and kits are shipped to patients doors to be completed in the privacy and comfort of home.SAN FRANCISCO PRWEB...
View ArticleFirst Wave Bio Inc. to Begin Clinical Trials of Novel SmallMolecule Therapy...
First Wave Bio Inc. a biopharmaceutical company developing novel therapeutics for the treatment of inflammatory bowel disease IBD and related autoimmune disorders today announced that it has received...
View Article